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Mitochondria are important cellular organelles in most metabolic processes and have a highly dynamic 
nature,  undergoing frequent ﬁssion and fusion.  The dynamic balance between ﬁssion and fusion plays 
critical roles in mitochondrial functions.  In recent studies,  several large GTPases have been identiﬁed 
as key molecular factors in mitochondrial ﬁssion and fusion.  Moreover,  the posttranslational modiﬁ-
cations of these large GTPases,  including phosphorylation,  ubiquitination and SUMOylation,  have 
been shown to be involved in the regulation of mitochondrial dynamics.  Neurons are particularly 
sensitive and vulnerable to any abnormalities in mitochondrial dynamics,  due to their large energy 
demand and long extended processes.  Emerging evidences have thus indicated a strong linkage 
between mitochondria and neurodegenerative diseases,  including Alzheimerʼs disease,  Parkinsonʼs 
disease and Huntingtonʼs disease.  In this review,  we will describe the regulation of mitochondrial 
dynamics and its role in neurodegenerative diseases.
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itochondria are cellular organelles well known 
for their important function in ATP synthesis 
through oxidative phosphorylation,  and traditionally 
regarded as the cellʼs powerhouse units.  However,  
mitochondria are more than simple powerhouses; they 
are also critical to many other cellular functions,  such 
as intermediary metabolism,  calcium homeostasis,  cell 
proliferation,  development and apoptosis [1-4].  On 
the other hand,  mitochondria are highly dynamic.  
They continuously move throughout cells and change 
their morphology by frequent fusion and ﬁssion events 
in response to cellular energy demands and environ-
mental challenges [5].  Under physiological condition,  
mitochondrial ﬁssion is well balanced with fusion to 
maintain the normal morphology,  number and function 
of the mitochondria [6,  7].  Mitochondria often 
appear as thread-like or tubular in morphology and 
form a dynamic network in most cells.  Although the 
precise molecular mechanisms are still not entirely 
understood,  some large GTPases and mitochondrial 
proteins,  such as Drp1,  Fis1,  Mfn1,  2,  OPA1 and 
so on,  have been identiﬁed as key molecular factors in 
mitochondrial ﬁssion or fusion [8-10].  However,  it is 
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still a mystery how mitochondria can respond to intra- 
or extra-cellular signals and stimulation through 
alterations in morphology.  Recent studies have sug-
gested that some speciﬁc signaling pathways and post-
translational modiﬁcations,  including phosphorylation,  
ubiquitination or SUMOylation of mitochondria-related 
proteins,  may be involved in the regulation of mito-
chondrial dynamics [11].
　 Although mitochondria are critical organelles for 
all cells,  neurons are also extremely dependent on 
normal mitochondrial function.  Neurons are highly 
specialized cells with long extended processes includ-
ing axons and dendrites.  Additionally,  the long 
extended neuronal processes are highly active in 
intercellular signal transduction by neurotransmitter 
release from synapses,  which requires large amounts 
of energy [12].  Therefore,  the ability of mitochon-
dria to fuse,  divide and migrate to provide energy 
throughout the extended neuronal processes is par-
ticularly important for synaptic functions (Fig.  1).  In 
addition to energy supply,  mitochondria also play a 
critical role in synaptic plasticity through the mainte-
nance of calcium homeostasis in the synaptic microen-
vironment by calcium buﬀering (Fig.  1B) [13].  
Furthermore,  an accumulation of mtDNA mutations is 
found in the brain with age and neurodegeneration [5,  
12,  14].  The coordinated mitochondrial fusion is 
important for the maintenance of mitochondrial DNA 
(mtDNA) stability [15,  16].  Taken together,  these 
ﬁndings demonstrate that neurons are very sensitive 
and vulnerable to mitochondrial dysfunction.  Emerging 
evidences also show that impaired mitochondrial 
dynamics and function are involved in the pathogenesis 
of neurodegenerative diseases,  such as Alzheimerʼs 












Fig. 1　 Mitochondria play important roles in neuronal functions.  A,  In neurons,  mitochondria not only distribute in the cell body but also 
travel to the long extended neuronal processes,  including the dendritic and axonal termini; B,  In synapses,  mitochondria provide suﬃcient 
ATP for synaptic activities,  such as neurotransmitter release and action potential ﬁring.  In addition,  uptake of calcium by mitochondria is 
important for the maintenance of calcium homeostasis,  synaptic functions and plasticity.
disease,  Parkinsonʼs disease and Huntingtonʼs disease 
[5,  7,  14].
　 In this review,  we will describe the current under-
standing of the regulation of mitochondrial dynamics,  
and discuss the impact of mitochondria on cellular 
function,  especially in neurodegenerative diseases.
Mitochondrial Fission and Fusion
　 In structure,  mitochondria are unique organelles 
containing a double membrane system.  The double 
membrane system separates mitochondria into 4 intra-
organelle compartments: the outer mitochondrial 
membrane (OMM),  inner mitochondrial membrane 
(IMM),  intermembrane space (IMS),  and matrix.  The 
IMM is highly folded into cristae,  within which the 
complexes of the electron transport chain and ATP 
synthases are enclosed.  Interestingly,  there is a 
unique 16-kilobase circular mitochondrial DNA 
(mtDNA) genome containing 37 genes essential for 
mitochondrial respiratory function,  although some 
mitochondrial proteins can be encoded by nuclear 
genes and subsequently transported into mitochondria 
[17,  18].
　 Mitochondria are also remarkably dynamic.  They 
transport throughout cells with frequent changes in 
morphology.  Mitochondrial morphology is controlled 
by a dynamic balance between ﬁssion and fusion.  The 
ﬁrst observation of mitochondrial ﬁssion and fusion 
events was in yeast [19,  20],  but this phenomenon 
has since been observed in all mammalian cells.  Under 
physiological conditions,  the coordinated mitochon-
drial ﬁssion and fusion maintain mitochondria as 
thread-like or tubular morphology in most cells [6].  
Disruption in the balance between ﬁssion and fusion 
not only changes the mitochondrial morphology,  but 
also inﬂuences the mobility of mitochondria and their 
distribution in cells [21-23].  In addition,  an abnor-
mality in mitochondrial ﬁssion or fusion may lead to 
mitochondrial pathology and inﬂuence cell survival [1,  
5,  24].  Emerging evidences also indicate that the 
mitochondrial dynamics may be altered in response to 
physiological demands,  environmental stimulations or 
pathological conditions [5].
　 In recent genetic studies,  some proteins have been 
identiﬁed as key molecular factors in the regulation of 
mitochondrial ﬁssion and fusion.  Interestingly,  the 
proteins required for ﬁssion are diﬀerent from those 
required for fusion in both yeast and mammalian cells 
(Table 1).  In yeast,  mitochondrial fusion requires 
Fzo1 and Mgm1 [25,  26].  Fzo1 is an OMM protein,  
containing an N-terminal GTPase domain for outer 
membrane fusion and a C-terminus for mitochondrial 
location [26].  In contrast,  Mgm1 localizes to the 
IMM and is responsible for fusion of the IMM [25].  
In mammalian cells,  mitofusin 1,  2 (Mfn1,  2) and 
optical atrophy 1 have been identiﬁed as the ortho-
logues of Fzo1 and Mgm1,  respectively.  It has been 
shown that Mfn1 and Mfn2 have similar topologies and 
share 81ｵ homology [9].  Mfn1 and Mfn2 are OMM 
proteins with a C-terminal coiled-coil structure 
homologous to Fzo1 and an N-terminal dynamin-like 
GTPase domain for mitochondrial fusion.  On the other 
hand,  OPA1 is an IMS protein with an N-terminal 
mitochondrial targeting sequence,  a transmembrane 
domain,  a central dynamin-related GTPase domain and 
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Table 1　 The proteins involved in mitochondrial fusion and ﬁssion in yeast and mammalian cells,  respectively
Name of proteins Location in mitochondria Function
Yeast
Fzo1 OMM OMM fusion
Mgm1 IMM and IMS IMM fusion
Dnm1 Cytosol and OMM OMM ﬁssion
Fis1 OMM Receptor of Dnm1
Mdv1 Cytosol and OMM Adaptor of Dnml and Fis1
Mammalian 
cells
Mfn1,  2 OMM OMM fusion
OPA1 IMM and IMS IMM fusion
Drp1 Cytosol and OMM OMM ﬁssion
hFis1 OMM Receptor of Drp1
a C-terminal helical domain [8].  Therefore,  these 
proteins for mitochondrial fusion are all large 
GTPases and respectively localized to the IMM,  
OMM and IMS.  Recent evidences suggest that Fzo1,  
Mfn1 and Mfn2 mediate OMM fusion by tethering 
outer membranes together via interactions of their 
coiled-coil domains in trans (Fig.  2A) [27].  In yeast,  
Mgm1 tethers IMM through the interaction with itself 
in trans [28].  Considering the sequence similarity 
between Mgm1 and OPA1,  the mechanism of IMM 
fusion in mammalian cells may be similar to that in 
yeast (Fig.  2A).  In mitochondrial fusion,  the OMM 
and IMM should fuse simultaneously in order to main-
tain the organelle integrity.  However,  it is still 
unclear how the fusion of OMM and IMM are coordi-
nated under physiological conditions.
　 In mitochondrial ﬁssion,  a distinct set of evolution-
arily conserved proteins (Table 1) are utilized.  Mito-
chondrial ﬁssion in yeast is regulated by dynamin 1 
(Dnm1) and Fis1,  a small protein on OMM [29],  
while in mammalian cells dynamin-related protein 1 
(Drp1) and hFis1 are required for mitochondrial ﬁs-
sion [10].  Dnm1 and Drp1 share highly similar amino 
acid sequences and domain structures with dynamin,  
which is a well known large GTPase involved in the 
regulation of vesicular traﬃc and endocytosis [30,  
31].  There are 3 conserved domains in Dnm1 and 
Drp1: an N-terminal GTPase domain,  a GTPase 
domain and a GTPase eﬀector domain (GED),  the 
latter of which regulates self-assembly and activation 
of GTP hydrolysis in the process of mitochondrial 
ﬁssion [30].  Without the pleckstrin homology (PH) 
domain for mitochondrial membrane targeting,  Dnm1 
and Drp1 are mostly distributed in the cytoplasm 
under physiological conditions [5,  32].  In mitochon-
drial ﬁssion,  Dnm1 and Drp1 can cluster into large 
foci at the ﬁssion sites (Fig.  2B) [33-35].  It has been 
proposed that Dnm1 and Drp1 may be recruited to the 
OMM via their respective molecular adaptors Fis1 and 
hFis1,  which localize to the OMM by a C-terminal 
conserved transmembrane helix [10,  29].  In yeast,  
Mdv1 is found to facilitate the interaction between 
Dnm1 and Fis1 (Fig.  2B) [36].  A recent study also 
suggests that Fis1 can directly bind Dnm1 in vitro,  and 
this interaction is negatively regulated by a short 
N-terminal region of Fis1 [37].  However,  the N-terminal 
region of Fis1 is not well conserved in mammals;  
Mdv1 is also not found in mammalian cells.  Additionally,  
hFis1 cannot rescue the phenotype of yeast cells lack-
ing Fis1 [38,  39].  In mammalian cells,  the interac-












Fig. 2　 Schematic model of mitochondrial fusion and ﬁssion.  A,  In mitochondrial fusion,  Mfn1,  Mfn2 and Fzo1 mediate OMM fusion by 
tethering outer membranes together via interactions of their coiled-coil domains in trans.  Coordinately,  OPA1/Mgm1 tethers IMM through 
an interaction with itself in trans.  Mitochondrial fusion also serves to mix and unify the mitochondrial compartments; B,  In mitochondrial 
ﬁssion,  Drp1 and Dnm1 are respectively recruited to the OMM via their molecular adaptors hFis and Fis1.  In yeast,  Mdv1 facilitates the 
interaction between Dnm1 and Fis1.  Scission of the mitochondrial membrane is induced under the GTPase activity of Drp1 and Dnm1.
tion between Drp1 and hFis1 can be detected by ﬂuo-
rescence resonance energy transfer and 
immunoprecipitation experiments,  although the inter-
action is transient and weak [10,  40].  Therefore,  the 
interaction between Drp1 and Fis1 in mammalian cells 
is likely to be a little diﬀerent from those occurring 
between the equivalent proteins in yeast.  When Dnm1 
or Drp1 are recruited to the OMM,  they may self-
assemble into spirals and cluster into large foci around 
mitochondria [33-35].  As mechanoenzymes similar to 
dynamin,  Dnm1 and Drp1 might reduce the mitochon-
drial diameter at possible ﬁssion sites and induce 
mitochondrial membrane constriction and scission by 
GTP hydrolysis [33,  35].
　 What is the role of ﬁssion and fusion in mitochon-
drial and cellular function? First,  mitochondrial 
number and morphology depend on the dynamic balance 
between fusion and ﬁssion [6].  Fusion might maintain 
mitochondria in an extended interconnected long 
thread-like or tubular network,  which is required for 
the intramitochondrial exchange of metabolic sub-
strates and the maintenance of respiratory capacity 
[41].  Moreover,  mtDNA is particularly vulnerable to 
reactive oxygen species (ROS)-mediated mutation 
[18].  The mutations accumulate with age and might 
result in mitochondrial dysfunction.  Mitochondrial 
fusion might serve to mix and unify the mitochondrial 
compartments (Fig.  2A),  which allows the comple-
mentation of mtDNA and counteracts respiratory 
deﬁciencies [15,  16].  Furthermore,  the connectivity 
of the mitochondrial network is important for response 
to calcium signals [42].  The fusion of mitochondria is 
also an essential step in certain developmental pro-
cesses,  such as embryonic development and spermato-
genesis [3,  4].  In contrast,  in mitochondrial ﬁssion,  
the tubular mitochondrial network divides and splits 
into numerous morphologically distinct small and iso-
lated spherical organelles.  Mitochondrial ﬁssion is 
very necessary in dividing cells,  since it ensures a 
suﬃcient number of functional mitochondria and the 
inheritance of mitochondria in newly formed daughter 
cells [2].  Fission is also important for the formation 
of synapses and dendritic spines in neurons [13].  
However,  excessive mitochondrial ﬁssion results in a 
breakdown of the mitochondrial network,  loss of the 
mtDNA,  respiratory defects and an increase in ROS,  
which actively participates in apoptosis [1,  5].
Regulation of Mitochondrial Dynamics
　 Mitochondrial fusion and ﬁssion are well balanced 
to meet with cellular energy needs,  cell growth,  dif-
ferentiation and extracellular environmental stimuli.  
How can mitochondrial dynamics respond eﬀectively to 
these events? Recent studies have shed light on the 
mechanism underlying the regulation of mitochondrial 
fusion and ﬁssion.  Emerging evidences indicate that 
three main posttranslational modiﬁcations of mitochon-
dria-related proteins i.e.,  phosphorylation,  ubiquitina-
tion and SUMOylation are likely involved in the regu-
lation of mitochondrial fusion and ﬁssion [11].  These 
modiﬁcations are also known to modulate protein-pro-
tein interactions,  subcellular localization,  protein 
degradation,  and activation of signaling pathways.
　 Phosphorylation. Phosphorylation of Drp1 is 
likely to be an eﬀective regulation of mitochondrial 
ﬁssion.  During mitosis,  mitochondrial ﬁssion occurs 
at the early mitotic phase,  and the interconnected 
mitochondrial networks begin to be restored in the 
late mitotic phase,  and subsequently divided into 
daughter cells.  Notably,  Drp1 was found to be spe-
ciﬁcally phosphorylated by Cdk1/cyclin B at Ser 585 
in mitosis.  Knockdown of endogenous Drp1 or expres-
sion of unphosphorylated mutant Drp1 S585A eﬀec-
tively reduces mitotic mitochondrial ﬁssion [43].  In 
our studies [23],  mitochondrial ﬁssion and the trans-
location of Drp1 from cytoplasm to mitochondria were 
triggered by high K＋ stimulation in neurons.  In the 
presence of high K＋ stimulation,  Drp1 was also spe-
ciﬁcally phosphorylated by CaMKIα at Ser600,  which 
is close to the phosphorylation site of Cdk1/cyclin B.  
We also found that CaMKIα-mediated phosphorylation 
of Drp1 facilitated the interaction between Drp1 and 
hFis1 in vitro.  In addition,  overexpression of Drp1 
S600A signiﬁcantly inhibited high K＋ induced mito-
chondrial ﬁssion.  Together,  these results indicate 
that phosphorylation of Drp1 by Cdk1/cyclin B and 
CaMKIα promotes mitochondrial ﬁssion in response 
to mitosis and neuronal excitation,  respectively.  On 
the other hand,  CaMKI and protein kinase A (PKA) 
are known to have overlapping substrate speciﬁcity.  
For example,  a common serine residue in synapsin I 
has been found to be phosphorylated in response to 
high K＋ treatment or increased cAMP levels [44].  
Recently,  PKA was also found to phosphorylate Drp1 
at Ser637 in the variable domain of humans and Drp1 
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at Ser656 in the conserved GED in rats.  Conversely,  
PKA phosphorylation has been shown to signiﬁcantly 
decrease the GTPase activity of Drp1 and inhibit 
mitochondrial ﬁssion [45,  46].  Therefore,  further 
studies will be needed to fully clarify the conﬂicts in 
the eﬀects of phosphorylations induced by diﬀerent 
kinases.  Additionally,  cyclin-dependent kinase 5 (Cdk5) 
has also been shown to act as a key upstream regula-
tor of mitochondrial ﬁssion.  Overexpression of Cdk5 
and p25 or p35 induces signiﬁcant caspase-indepen-
dent mitochondrial ﬁssion.  Conversely,  knockdown of 
Cdk5 by RNAi reduces mitochondrial ﬁssion [47,  
48].  Therefore,  it will be very interesting to further 
examine whether Cdk5 regulates mitochondrial ﬁssion 
by phosphorylating some mitochondria-related pro-
teins.
　 Ubiquitination. Ubiquitination is mediated by 
the conjugation of ubiquitin,  a small conserved pep-
tide,  to substrate proteins through a series of complex 
enzymatic reactions [49].  Ubiquitination plays an 
important role in selective protein degradation,  mem-
brane protein traﬃcking,  and regulates a variety of 
cellular processes,  including the cell cycle,  signal 
transduction and cell transformation [50].  In recent 
studies,  MARCH5,  a mitochondrial E3 ubiquitin ligase,  
was identiﬁed as a critical regulator of mitochondrial 
dynamics through the ubiquitylation of certain mito-
chondrial proteins,  including Drp1 and Fis1 [51].  
MARCH5 is an OMM protein consisting of an 
N-terminal RING ﬁnger domain critical for the ubiq-
uitin transfer activity of several E3 ubiquitin ligases 
and four transmembrane domains [51-53].  MARCH5 
activity is likely to regulate the subcellular traﬃcking 
of Drp1 through the correct assembly at scission sites 
or through the disassembly of ﬁssion complexes [53].  
However,  the eﬀect of MARCH5 on mitochondrial 
dynamics is still controversial,  with various groups 
reporting diﬀerent results.  In the studies of Nakamura 
and Yonashiro,  it was found that mutations in the 
MARCH5 RING domain or MARCH RNAi caused 
mitochondrial ﬁssion.  Overexpression of MARCH5 
promoted mitochondrial fusion in an Mfn2-dependent 
manner [51,  52].  Conversely,  in Karbowskiʼs stud-
ies,  MARCH5 RING mutants and MARCH RNAi 
induced mitochondrial fusion through the inhibition of 
ﬁssion [53].  Therefore,  the mechanism and role of 
ubiquitination in mitochondrial dynamics may still 
require more comprehensive investigation in the 
future.
　 SUMOylation. SUMOylation is another highly 
transient post-translational protein modiﬁcation enzy-
mologically parallel to ubiquitination.  Four mamma-
lian SUMO isoforms have been identiﬁed,  i.e.,  
SUMO1～4 [54-56].  In SUMOylation,  substrate 
proteins are conjugated to SUMO by a number of 
speciﬁc enzymes to form SUMO-substrate complexes.  
The SUMO-protein complex is in a transient state,  
and can again be divided into SUMO and free sub-
strate proteins for the next round of modiﬁcation.  
SUMOylation thus facilitates rapid response to envi-
ronmental cues by cells [57].  In recent studies [56,  
58,  59],  Drp1 has been identiﬁed as a target protein 
of SUMO modiﬁcation.  Drp1 interacts with the 
SUMO-conjugating enzyme Ubc9 as a prerequisite for 
SUMO modiﬁcation [56].  Two clusters of lysine 
residues within Drp1 have also been identiﬁed as 
noncanonical conjugation sites for SUMO.  Addi-
tionally,  SUMO1 often colocalizes with Drp1 at 
mitochondrial ﬁssion sites in living imaging [58].  The 
overexpression of SUMO1 protects Drp1 from degra-
dation,  resulting in a more stable,  active pool of 
Drp1,  and dramatically enhances mitochondrial ﬁssion 
[58].  On the other hand,  the cytosolic pool of 
SENP5,  a SUMO speciﬁc protease,  catalyzes the 
cleavage of SUMO1 from Drp1,  and regulates the 
sensitivity of Drp1 to degradation.  Overexpression of 
SENP5 protects mitochondria from SUMOl-induced 
ﬁssion.  While silencing of SENP5 increases Drp1 
SUMOylation and induces mitochondrial ﬁssion [59].  
Recently,  it is also found that three SUMO isoforms,  
SUMO1～3,  are all involved in the SUMOylation of 
Drp1 [56].  Taken together,  these evidences strongly 
support the notion that SUMOylation plays an impor-
tant role in the regulation of mitochondrial dynamics.
Mitochondrial Dynamics and 
Neurodegenerative Diseases
　 Neurons are metabolically active cells with high 
energy demands.  In morphology,  neurons are also 
unique,  containing many long extended processes,  
such as axons and dendrites.  In some motor neurons,  
the axons even extend up to one meter.  As a result,  
the supply of energy throughout distant neuronal 
processes is highly dependent on mitochondrial dynam-
ics (Fig.  1A).  In addition,  the ability of mitochondria 
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to buﬀer calcium,  which modulates neurotransmitter 
release and action potential ﬁring is very important 
for the maintenance of synaptic functions (Fig.  1B) 
[12,  13].  Therefore,  neurons are much more sensi-
tive and vulnerable to mitochondrial dysfunction than 
any other cells.  A mutation in mitochondria-related 
proteins may cause abnormal mitochondrial dynamics 
and neuropathy [60-63].  For example,  a mutation in 
the GTPase domain of OPA1 causes dominant optic 
atrophy (DOA),  resulting in retinal ganglion cell death 
and progressive loss of vision [60,  61].  Mutation in 
Mfn2 leads to Charcot-Marie-Tooth subtype 2A 
(CMT2A),  a peripheral neuropathy with axonal degra-
dation in sensory and motor neurons [62,  63].  Aside 
from DOA and CMT2A,  emerging evidences show that 
dysfunction in mitochondrial dynamics has a strong 
linkage with neurodegenerative diseases including 
Alzheimerʼs disease,  Parkinsonʼs disease and 
Huntingtonʼs disease [5,  7,  14].
　 Alzheimerʼs disease. Alzheimerʼs disease (AD) 
is the most common neurodegenerative disorder and is 
pathologically characterized by neuronal death,  neu-
roﬁbrillary tangles and beta-amyloid (Aβ) plaques in 
cerebral cortex.  The symptoms of AD include pro-
gressive cognitive dysfunction and memory impairment.  
Recent evidences indicate that synaptic loss and dys-
function make important contributions to the memory 
impairment and cognitive dysfunction in AD [64,  65].  
It has also been reported that mitochondria are impor-
tant for synaptic development and plasticity,  with 
abnormalities in mitochondrial dynamics leading to 
synaptic dysfunction and loss [13].  In the brains of 
AD patients,  signiﬁcant alterations in mitochondrial 
cristae,  the accumulation of osmiophilic material and 
signiﬁcant decreases in mitochondrial size are found 
prominently in neurons [66].  Mitochondria are redis-
tributed away from axons in the pyramidal neurons 
[67].  The levels of mitochondrial ﬁssion and fusion 
proteins are also changed,  e.g.,  the levels of Drp1,  
OPA1,  Mfn1 and Mfn2 are signiﬁcantly decreased and 
the levels of hFis1 are increased [22,  67,  68].  In the 
brains of AD model mice,  Aβ,  the key mediator of 
AD,  localizes to mitochondria,  and promotes mito-
chondrial dysfunction and oxidative damage [68].  
These evidences indicate the strong link between 
mitochondrial dynamics and the pathogenesis of AD.  
In vitro,  the overexpression of amyloid precursor 
protein (APP) in M17 cells has been associated with 
signiﬁcant mitochondrial fragmentation,  decreased 
levels of Drp1 and OPA1,  and redistribution of mito-
chondria around the perinuclear area [68],  which is 
very similar to the phenotype in vivo.  Interestingly,  
oligomeric amyloid-beta-derived diﬀusible ligands 
(ADDLs) cause mitochondrial fragmentation,  and also 
reduce the mitochondrial density in neuronal pro-
cesses.  More importantly,  the ADDL-induced synap-
tic changes,  such as loss of dendritic spines and syn-
apses,  correlate with abnormal mitochondrial 
distribution [67].  The overexpression of Drp1 can 
prevent ADDL-induced synaptic loss,  likely through 
the repopulation of neuronal processes with mitochon-
dria [67].  Furthermore,  Cdk5 has been identiﬁed as 
an important mediator in AD pathogenesis through the 
hyperphosphorylation of some microtubule-associated 
proteins such as Tau [69,  70].  Recently,  it has also 
been reported that Cdk5 can act as an upstream 
mediator of mitochondrial ﬁssion [47,  48].  Taken 
together,  these evidences strongly indicate that 
abnormal mitochondrial dynamics plays an important 
role in AD pathogenesis.
　 Parkinsonʼs disease. Parkinsonʼs disease (PD) 
is the second most common neurodegenerative disease;  
PD is caused by the loss of dopaminergic neurons in 
the substantia nigra,  and is characterized by progres-
sive symptoms of movement disorder.  Both chemical 
and genetic evidences have strongly suggested that 
mitochondrial dysfunction is associated with PD [14,  
71].  A deﬁciency in complex 1 of the electron trans-
port chain has been found in the substantia nigra from 
PD patients [72-74].  The toxin 1-methyl 4-phenyl-
1, 2, 3, 6-tetra hydropyridine (MPTP),  which impairs 
respiratory complex 1,  can also evoke Parkinsonʼs-
like disease in human and animal models [75,  76].  
More recently,  mutations in two genes,  Pink1 and 
Parkin,  were identiﬁed in hereditary PD [14,  71,  
72].  Pink1 is a serine/threonine kinase localized to 
both mitochondria and cytoplasm,  and acts upstream 
of Parkin in a common genetic pathway [77].  In 
Drosophila,  the 2 genes are also important for mito-
chondrial dynamics through promotion of ﬁssion and/
or inhibition of fusion events [78,  79].  In human 
dopaminergic neurons or primary cultured mouse 
neurons,  Pink1 deﬁciency results in an age-related 
reduction in basal viability accompanied by mitochon-
drial morphometric abnormalities [80].  Moreover,  a 
Parkin-defective mutation in Drosophila leads to dop-
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aminergic degeneration and mitochondrial abnormali-
ties [81].  In addition,  Parkin-knockout and Parkin-
mutant transgenic mice also exhibit mitochondrial 
respiratory defects and morphological abnormalities 
[82].
　 Huntingtonʼs disease. Huntingtonʼs disease 
(HD),  the hereditary autosomal dominant neurodegen-
erative disorder,  is caused by an expansion of CAG 
repeats within the huntingtin (Htt) gene.  Abnormal-
ities in mitochondria,  such as reduced mitochondrial 
movement and mitochondrial ultrastructural changes,  
have also been found in HD patients or mouse trans-
genic HD models [83,  84].  The direct experimental 
evidence linking neurodegeneration in HD to mitochon-
dria is the eﬀect of 3-nitropropionic acid,  an irrevers-
ible inhibitor of complex II.  It has been shown that 
3-nitropropionic acid can induce signiﬁcant mitochon-
drial fragmentation in rat cortical neurons,  and causes 
HD-like symptoms in animal models [85].  Addi-
tionally,  overexpression of the mutant Htt74Q leads 
to signiﬁcant mitochondrial ﬁssion and cell death,  
which can be rescued by overexpression of Drp1K38A 
or Mfn2 [86].  Importantly,  the fragments of Htt have 
been found to associate with mitochondria,  and to 
interfere with their microtube-associated transport,  
which leads to abnormal axonal traﬃcking of mito-
chondria to and from the synapses [84].  This sug-
gests that Htt overexpression may alter the mitochon-
drial dynamics,  although the molecular mechanism 
remains to be determined.
Conclusions
　 We here discussed the mechanism of mitochondrial 
dynamics and its linkage with neurodegenerative dis-
ease.  Mitochondrial ﬁssion and fusion are not isolated 
events.  Under physiological conditions,  they are well 
coordinated to meet with the energy demands and 
various activities of cells.  Mitochondria-related 
GTPases and their posttranslational modiﬁcations,  
including phosphorylation,  ubiquitination and 
SUMOylation,  are involved in mitochondrial ﬁssion/
fusion.  An improved understanding of mitochondrial 
ﬁssion and fusion and their mechanisms would be of 
great beneﬁt in evaluating their functions in physiology 
and pathology.  Although the precise molecular mecha-
nisms of mitochondrial dynamics in neurodegenerative 
diseases are still not entirely understood,  it is becom-
ing increasingly clear that the disruption of balance 
between mitochondrial ﬁssion and fusion plays an 
important role in neurodegenerative diseases.  An 
improved understanding of the linkage between mito-
chondrial dynamics and neurodegeneration would be 
invaluable in the development of new therapeutic 
interventions which target mitochondrial ﬁssion and 
fusion for the treatment of neurodegenerative dis-
eases.
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